Quarterly report pursuant to Section 13 or 15(d)

Financial Information Relating to Reportable Segments (Detail)

v2.3.0.15
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands
3 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Segment Reporting Information [Line Items]    
External sales $ 77,596 $ 67,945
Earnings before income taxes 40,500 38,953
Biotechnology
   
Segment Reporting Information [Line Items]    
External sales 72,303 63,041
Earnings before income taxes 39,984 38,460
Hematology
   
Segment Reporting Information [Line Items]    
External sales 5,293 4,904
Earnings before income taxes 1,918 1,922
Reportable Segment
   
Segment Reporting Information [Line Items]    
Earnings before income taxes 41,902 40,382
Unallocated Amount to Segment
   
Segment Reporting Information [Line Items]    
Earnings before income taxes $ (1,402) $ (1,429)